Cargando…
Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3
Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/ https://www.ncbi.nlm.nih.gov/pubmed/30564333 http://dx.doi.org/10.1002/ccr3.1891 |
_version_ | 1783380503466868736 |
---|---|
author | Sannino, Mario Lodi, Giuseppe Dethlefsen, Markus Wied Nisticò, Steven Paul Cannarozzo, Giovanni Nielsen, Michael Canova Engelbrecht |
author_facet | Sannino, Mario Lodi, Giuseppe Dethlefsen, Markus Wied Nisticò, Steven Paul Cannarozzo, Giovanni Nielsen, Michael Canova Engelbrecht |
author_sort | Sannino, Mario |
collection | PubMed |
description | Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin. |
format | Online Article Text |
id | pubmed-6293188 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62931882018-12-18 Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 Sannino, Mario Lodi, Giuseppe Dethlefsen, Markus Wied Nisticò, Steven Paul Cannarozzo, Giovanni Nielsen, Michael Canova Engelbrecht Clin Case Rep Case Reports Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin. John Wiley and Sons Inc. 2018-10-25 /pmc/articles/PMC6293188/ /pubmed/30564333 http://dx.doi.org/10.1002/ccr3.1891 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Case Reports Sannino, Mario Lodi, Giuseppe Dethlefsen, Markus Wied Nisticò, Steven Paul Cannarozzo, Giovanni Nielsen, Michael Canova Engelbrecht Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title | Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title_full | Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title_fullStr | Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title_full_unstemmed | Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title_short | Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3 |
title_sort | fluorescent light energy: treating rosacea subtypes 1, 2, and 3 |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293188/ https://www.ncbi.nlm.nih.gov/pubmed/30564333 http://dx.doi.org/10.1002/ccr3.1891 |
work_keys_str_mv | AT sanninomario fluorescentlightenergytreatingrosaceasubtypes12and3 AT lodigiuseppe fluorescentlightenergytreatingrosaceasubtypes12and3 AT dethlefsenmarkuswied fluorescentlightenergytreatingrosaceasubtypes12and3 AT nisticostevenpaul fluorescentlightenergytreatingrosaceasubtypes12and3 AT cannarozzogiovanni fluorescentlightenergytreatingrosaceasubtypes12and3 AT nielsenmichaelcanovaengelbrecht fluorescentlightenergytreatingrosaceasubtypes12and3 |